FDA Acts on Dietary Supplements Containing DMHA and Phenibut
DMHA and Phenibut On April 10, 2019, the FDA issued 12 warning letters to companies whose dietary supplement products are in violation of the law. The FDA issued 9 warning letters to companies whose products are marketed as dietary supplements and labeled to contain DMHA. DMHA has been found in numerous dietary supplement products, often marketed […]
FDA Acts on Dietary Supplements Containing DMHA and Phenibut Read More »